Laryngeal Squamous Cell Carcinoma Clinical Trials

18 clinical trials for Laryngeal Squamous Cell Carcinoma across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer — RECRUITING · PHASE2
• Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation — RECRUITING · NA
• Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery — RECRUITING · PHASE2
• Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer — RECRUITING · PHASE2
• Intralesional Chemotherapy (IC): Cisplatin + Epinephrine — RECRUITING · PHASE2
• Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer — RECRUITING · PHASE2
• Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study. — RECRUITING · PHASE3
• Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer — RECRUITING · PHASE1
• European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] — RECRUITING · PHASE2
• Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin — COMPLETED · PHASE2
• Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors — TERMINATED · PHASE2
• Decisional Regret in Open Partial Horizontal Laryngectomy — OTHER
• Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer — WITHDRAWN · PHASE2
• Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy. — OTHER
• Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy — TERMINATED · PHASE1
• IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag Governorate — OTHER
• A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer — COMPLETED · NA

Refine this search